Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic
- Conditions
- Alcoholic NeuropathyLiver FailureDEPRESSIVE DISORDERHEART DISEASE
- Interventions
- Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
- Registration Number
- NCT01081197
- Lead Sponsor
- Helse Nord-Trøndelag HF
- Brief Summary
Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.
The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).
- Detailed Description
Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway
- Not consenting to participate
- Not able to consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Out-day patients' clinic Psychiatric and somatic examinations and ,if clinical indicated, treatment Alcohol abusers referred to out-day patients' clinic which consent to participate in the study
- Primary Outcome Measures
Name Time Method Prevalence of different kinds of somatic disease 3 months after inclusion Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.
- Secondary Outcome Measures
Name Time Method Prevalence of former somatic disease 3 months after inclusion Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.
Outcome of psychiatric and somatic treatment of alcohol abusers 1 year after stopped inclusion Quality of life and score of somatic and psychiatric health 1 year after inclusion
Trial Locations
- Locations (1)
Levanger Hospital, Dep. of Psychiatry
🇳🇴Levanger, Norway